{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:54:51Z","timestamp":1788929691474,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.msard.2024.105886","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T22:24:22Z","timestamp":1726352662000},"page":"105886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset"],"prefix":"10.1016","volume":"91","author":[{"given":"Franz Felix","family":"Konen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gingele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"H\u00fcmmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"M\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lena","family":"Streichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Reza","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Grote-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Seeliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominica","family":"Ratuszny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin Fritz","family":"Jendretzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Tkachenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1260-1650","authenticated-orcid":false,"given":"Philipp","family":"Schwenkenbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0001","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1002\/hsr2.489","article-title":"The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease-modifying therapies","volume":"5","author":"Ahmadi","year":"2022","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1756285616666741","article-title":"Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management","volume":"10","author":"Bittner","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B cells in multiple sclerosis and related disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105886_bib0004","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3389\/fimmu.2019.02085","article-title":"Systemic and intra-nodal activation of NK cells after rituximab monotherapy for follicular lymphoma","volume":"10","author":"Enqvist","year":"2019","journal-title":"Front. Immunol."},{"issue":"1-2","key":"10.1016\/j.msard.2024.105886_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.imlet.2012.05.004","article-title":"CD20+ T cell numbers are decreased in untreated HIV-1 patients and recover after HAART","volume":"146","author":"F\u00f6rster","year":"2012","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells8010012","article-title":"Ocrelizumab depletes CD20\u207a T cells in multiple sclerosis patients","volume":"8","author":"Gingele","year":"2018","journal-title":"Cells."},{"issue":"4","key":"10.1016\/j.msard.2024.105886_bib0007","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4103\/1673-5374.266913","article-title":"Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab","volume":"15","author":"Gingele","year":"2020","journal-title":"Neural. Regen. Res."},{"issue":"2","key":"10.1016\/j.msard.2024.105886_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.990140212","article-title":"CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes","volume":"14","author":"Hultin","year":"1993","journal-title":"Cytometry"},{"issue":"7","key":"10.1016\/j.msard.2024.105886_bib0009","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.msard.2024.105886_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.msard.2014.06.001","article-title":"CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination","volume":"3","author":"Holley","year":"2014","journal-title":"Mult. Scler Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.105886_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus Interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.msard.2024.105886_bib0012","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus teriflunomide in multiple sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.msard.2024.105886_bib0013","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V70.5.1316.1316","article-title":"Flow cytometric analysis of human bone marrow. II. normal B lymphocyte development","volume":"70","author":"Loken","year":"1987","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3324\/haematol.2008.001628","article-title":"Anti-CD20 monoclonal antibodies: historical and future perspectives","volume":"95","author":"Lim","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.msard.2024.105886_bib0015","doi-asserted-by":"crossref","first-page":"e1157","DOI":"10.1212\/NXI.0000000000001157","article-title":"Influence of previous disease-modifying drug exposure on t-lymphocyte dynamic in patients with multiple sclerosis treated with ocrelizumab","volume":"9","author":"Landi","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2024.105886_bib0016","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4049\/jimmunol.1400118","article-title":"Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients","volume":"193","author":"Palanichamy","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2024.105886_bib0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.msard.2024.105886_bib0018","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2024.105886_bib0028","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.1600089","article-title":"Features of human CD3+CD20+ T cells","volume":"197","author":"Schuh","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2024.105886_bib0019","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"51","key":"10.1016\/j.msard.2024.105886_bib0020","doi-asserted-by":"crossref","first-page":"25800","DOI":"10.1073\/pnas.1915309116","article-title":"Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis","volume":"116","author":"Sabatino","year":"2019","journal-title":"Proc. Natl. Acad Sci. U S A."},{"issue":"5","key":"10.1016\/j.msard.2024.105886_bib0021","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s10072-022-06582-y","article-title":"Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis","volume":"44","author":"Saidha","year":"2023","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.msard.2024.105886_bib0022","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","article-title":"CD20: a regulator of cell-cycle progression of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol. Today"},{"issue":"2","key":"10.1016\/j.msard.2024.105886_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105886_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awy301","article-title":"Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis","volume":"142","author":"von Essen","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2024.105886_bib0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200004","article-title":"Ofatumumab modulates inflammatory T cell responses and migratory potential in patients with multiple sclerosis","volume":"9","author":"von Essen","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3-4","key":"10.1016\/j.msard.2024.105886_bib0026","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.imbio.2007.10.012","article-title":"New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles","volume":"213","author":"Wilk","year":"2008","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.msard.2024.105886_bib0027","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.24998","article-title":"Depletion of functionally active CD20+ T cells by rituximab treatment","volume":"60","author":"Wilk","year":"2009","journal-title":"Arthritis Rheum."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:30:32Z","timestamp":1732336232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"alternative-id":["S2211034824004620"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105886","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105886"}}